Avenue Therapeutics, Inc.
ATXI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001644963
No open-market purchases or sales by Avenue Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Avenue Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −8 vs. Q2 2021
- Shares held
- 1.09M
- −60.7K (−5.3%) vs. Q2 2021
- Total value
- $1.62M
- −$1.26M (−43.7%) vs. Q2 2021
- New holders
- 3
- 6 more added
- Sold out
- 11
- 8 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATXI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 7 | $385.3K |
| Q3 2024 | 8 | $491.8K |
| Q2 2024 | 9 | $407.2K |
| Q1 2024 | 14 | $168.9K |
| Q4 2023 | 15 | $52.4K |
| Q3 2023 | 14 | $157.3K |
| Q2 2023 | 12 | $849.4K |
| Q1 2023 | 14 | $532.7K |
| Q4 2022 | 14 | $520.5K |
| Q3 2022 | 11 | $766.0K |
| Q2 2022 | 19 | $181.0K |
| Q1 2022 | 17 | $503.0K |
| Q4 2021 | 18 | $2.14M |
| Q3 2021 | 21 | $1.62M |
| Q2 2021 | 29 | $2.88M |
| Q1 2021 | 34 | $11.1M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Avenue Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 273 | $0 | 0.00% | −1,421−83.9% | Reduced |
| Royal Bank of Canada | 209 | $0 | 0.00% | −1,046−83.3% | Reduced |
| Morgan Stanley | 122 | $0 | 0.00% | −61−33.3% | Reduced |
| BNP Paribas Arbitrage, SA | 133 | $198 | 0.00% | 00.0% | Unchanged |
| Capital Analysts, LLC | 601 | $1.00K | 0.00% | +601 | New |
| Barclays PLC | 1,125 | $2.00K | 0.00% | −953−45.9% | Reduced |
| UBS Group AG | 6,931 | $10.0K | 0.00% | +5,600+420.7% | Added |
| Northern Trust Corp | 13,767 | $21.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 16,704 | $25.0K | 0.00% | +5,331+46.9% | Added |
| HRT Financial LP | 19,704 | $29.0K | 0.00% | −4,916−20.0% | Reduced |
| Kestra Advisory Services, LLC | 22,500 | $34.0K | 0.00% | +22,500 | New |
| Citadel Advisors LLC | 27,555 | $41.0K | 0.00% | +27,555 | New |
| Nantahala Capital Management, LLC | 30,211 | $45.0K | 0.00% | 00.0% | Unchanged |
| Emfo, LLC | 43,590 | $65.0K | 0.06% | 00.0% | Unchanged |
| BlackRock Inc. | 47,857 | $72.0K | 0.00% | −101−0.2% | Reduced |
| Wells Fargo & Company | 48,036 | $72.0K | 0.00% | +47,994+114,271.4% | Added |
| Millennium Management LLC | 65,887 | $98.0K | 0.00% | −7,002−9.6% | Reduced |
| Geode Capital Management, LLC | 84,346 | $125.0K | 0.00% | +4,790+6.0% | Added |
| National Asset Management, Inc. | 89,237 | $133.0K | 0.00% | −36,800−29.2% | Reduced |
| Renaissance Technologies LLC | 118,100 | $176.0K | 0.00% | +39,786+50.8% | Added |
| Vanguard Group Inc | 452,653 | $675.0K | 0.00% | +2,671+0.6% | Added |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −35,121−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −30,400−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −26,373−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −23,224−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −14,398−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,359−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,864−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −10,554−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −665−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −198−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −60−100.0% | Sold out |